SENSEX NIFTY

Breast Cancer

Mar 02, 2017 at 19:00 | Source: PTI
"Once the designated authority has given approval, you cannot say prima facie you have case over that. Till that (approval) is disturbed by an order of the court, it will remain," a bench of justices Badar Durrez Ahmed and Sanjeev Sachdeva said.
Feb 22, 2017 at 20:38 | Source: PTI
The Delhi High Court today told Swiss pharma major Roche that it "cannot hang on to" breast cancer drug Trastuzumab, innovated by it, for the rest of its life after having enjoyed the fruits of its patent.
Feb 08, 2017 at 10:12 | Source: PTI
"As per Indian Council of Medical Research's National Cancer Registry programme, there would be an estimated 1,28,451 cases of mouth cancer, 1,79,790 of breast cancer and 1,04,060 of cervical cancer in the country by 2020.
Jan 18, 2017 at 15:16 | Source: Moneycontrol.com
Zydus Cadila has received the final approval from the USFDA to market Methotrexate tablets USP, 2.5 mg, a chemotherapy drug used for leukemias, lymphomas, breast cancer, lung cancer, and head and neck cancer and other cancers.
Jan 12, 2017 at 08:43 | Source: CNBC-TV18
Following US president-elect Donald Trumps explosive speech last night where he lambasted the domestic pharma companies for outsourcing work, pharma stocks are likely to be in limelight today.
Jan 12, 2017 at 08:21 | Source: Moneycontrol.com
Bengaluru-based biopharmaceutical firm Biocon on Wednesday said US drug regulator has accepted its partners Mylans biologics license application (BLA) for the proposed biosimilar of breast cancer drug Trastuzumab through the 351(k) pathway.
Dec 27, 2016 at 15:41 | Source: Moneycontrol.com
This study was the last major step of a multiple-phased programme to demonstrate that proposed biosimilar trastuzumab meets the criteria for equivalence in comparison to branded trastuzumab.
Oct 22, 2016 at 17:42 | Source: PTI
PTI,Yoga guru Baba Ramdev,Patanjali Group,United States,US visa,Chief Minister Shivraj Singh Chouhan,Madhya Pradesh,Finance Minister Arun Jaitley
Sep 19, 2016 at 16:40 | Source: PTI
Glenmark Pharmaceuticals todaysaid it has entered into an agreement with US-based ParticleSciences Inc to develop and market a generic version ofCelgene's ABRAXANE which is used in treatments of breast andlung cancers.
Aug 26, 2016 at 09:13 | Source: CNBC-TV18
The European Medicines Agency (EMA) has accepted to review Mylan and Biocons application for a biosimilar called Trastuzumab, used for certain breast and gastric cancers.
Messages on Breast Cancer »

savera_patn
a

Platinum Member

43 Followers

Biocon  

http://t.in.com/e6Rv Mylan and partner Biocon cleared another hurdle with their version of Roche’s breast cancer med Herceptin, one of the biggest biosim targets in the market.

8.48 PM Mar 14th

pennystktra
der

New Member

2 Followers

Biocon  

Biocon and Mylan will now be able to sell their version of the drug to treat metastatic breast cancer, gastric cancer and early breast cancer, until further orders from the Court. Counsel for Biocon and Reliance Life Sciences, Pratibha Singh said that the interim order reiterates that India does

2.04 PM Mar 6th

pennystktra
der

New Member

2 Followers

Biocon  

The legal battle involving drugmaker Roche s breast cancer drug Trastuzumab took a significant turn on Friday with the Delhi High Court allowing drugmakers Biocon and Mylan to sell their version of the biosimilar drug for three treatment indications.

2.03 PM Mar 6th

Wire News

Platinum Member

732 Followers

News Now  

Swiss pharma major Roche cannot prima facie have a say against the sale and marketing of breast cancer medicines of drug firms Biocon and Mylan once the Drugs Controller General of India (DCGI) has approved it, Delhi High Court said today.

7.06 PM Mar 2nd

News Flash

Platinum Member

1469 Followers

Just Posted  

CNBC-TV18 ALERT : Trastuzumab Is Used In Treatment Of Certain Types Of Breast Cancer

11.15 AM Mar 2nd

Wire News

Platinum Member

732 Followers

News Now  

The Delhi High Court today told Swiss pharma major Roche that it "cannot hang on to" breast cancer drug Trastuzumab, innovated by it, for the rest of its life after having enjoyed the fruits of its patent.

8.38 PM Feb 22nd

Khushi1979

New Member

2 Followers

GAIL  

Source:----BS:----) Strong growth prospects: In Biocon, investors see a blockbuster pipeline US nod to application for breast cancer drug is latest positive for the stock Ujjval Jauhari | New Delhi January 18, 2017 Last Updated at 10:53 IST

10.55 AM Jan 19th

k.v.renga

Platinum Member

1522 Followers

Biocon  

Source:----BS:----) Strong growth prospects: In Biocon, investors see a blockbuster pipeline US nod to application for breast cancer drug is latest positive for the stock Ujjval Jauhari | New Delhi January 18, 2017 Last Updated at 10:53 IST

9.48 PM Jan 18th

BSE/NSE Announcer

Platinum Member

22641 Followers

Cadila Health  

Zydus Cadila has received the final approval from the USFDA to market Methotrexate tablets USP, 2.5 mg, a chemotherapy drug used for leukemias, lymphomas, breast cancer, lung cancer, and head and neck cancer and other cancers.

3.16 PM Jan 18th

stock specific

Platinum Member

305 Followers

Biocon  

USFDA to review Biocon-Mylan`s biosimilar drug for breast cancer news may give the push for the biocon share price to 1025 Read more at:

11.56 PM Jan 11th

News across the web »
Follow us on
Available On